利民股份(002734.SZ):與蘇州利民生物將合計持有欣榮仁和100%合夥份額
格隆匯 7 月 30日丨利民股份(002734.SZ)公佈,公司於2020年7月30日召開第四屆董事會第十六次會議,審議通過《關於公司及子公司收購合併報表範圍內有限合夥企業合夥份額的議案》。公司決定使用自有或自籌資金6170萬元收購四川金東迪科技有限公司(“金東迪”或“轉讓方”)、河北新融金融服務有限公司(“河北新融”或“轉讓方”)在欣榮仁和享有的相應的合夥企業財產份額及相關的合夥權益。蘇州利民生物決定使用自有或自籌資金1190萬元收購北京欣榮投資管理有限公司(“欣榮投資”或“轉讓方”)在欣榮仁和享有的相應的合夥企業財產份額及相關的合夥權益。此次交易完成後,公司與蘇州利民生物將合計持有合夥企業100%的合夥份額。
此次交易完成後,公司與全資子公司蘇州利民生物科技有限責任公司(“蘇州利民生物”或“受讓方”)將合計持有新疆欣榮仁和股權投資有限合夥企業(“欣榮仁和”或“合夥企業”)100%的合夥份額。
此次公司及子公司收購合併報表範圍內合夥企業的合夥份額,是公司對控股子公司及合夥企業進行的有效整合,有利於實現收購威遠資產組時的聯合投資方順利退出,促進併購後集團進一步融合,提升管理效率,以更好地實現公司未來發展戰略。此次交易完成後,公司與全資子公司蘇州利民生物將合計持有合夥企業100%的合夥份額,並通過合夥企業持有威遠資產組25%的股權。此次交易不會導致公司合併財務報表範圍發生變化,符合公司整體利益,不會對公司財務和經營狀況產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.